| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Angiotensin-receptor blockade, cancer, and concerns
|
Böhm, Michael
|
|
2010
|
11 |
9 |
p. 818-819
2 p.
|
article
|
| 2 |
Angiotensin-receptor blockade, cancer, and concerns
|
Barrios, Vivencio
|
|
2010
|
11 |
9 |
p. 819-820
2 p.
|
article
|
| 3 |
Angiotensin-receptor blockade, cancer, and concerns
|
Meredith, Peter A
|
|
2010
|
11 |
9 |
p. 819-
1 p.
|
article
|
| 4 |
Angiotensin-receptor blockade, cancer, and concerns
|
Goldstein, Mark R
|
|
2010
|
11 |
9 |
p. 817-818
2 p.
|
article
|
| 5 |
Angiotensin-receptor blockade, cancer, and concerns
|
Julius, Stevo
|
|
2010
|
11 |
9 |
p. 820-821
2 p.
|
article
|
| 6 |
Angiotensin-receptor blockade, cancer, and concerns – Authors' reply
|
Sipahi, Ilke
|
|
2010
|
11 |
9 |
p. 821-822
2 p.
|
article
|
| 7 |
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
|
Masi, Gianluca
|
|
2010
|
11 |
9 |
p. 845-852
8 p.
|
article
|
| 8 |
Cyanine dyes in optical imaging of tumours
|
Shi, Chunmeng
|
|
2010
|
11 |
9 |
p. 815-816
2 p.
|
article
|
| 9 |
Does the existing standard of care increase glioblastoma energy metabolism?
|
Seyfried, Thomas N
|
|
2010
|
11 |
9 |
p. 811-813
3 p.
|
article
|
| 10 |
Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk
|
Speicher, Michael R
|
|
2010
|
11 |
9 |
p. 890-898
9 p.
|
article
|
| 11 |
Expression of concern—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
|
Collingridge, David
|
|
2010
|
11 |
9 |
p. 813-814
2 p.
|
article
|
| 12 |
Foundation hospitals
|
Burki, Talha
|
|
2010
|
11 |
9 |
p. 823-
1 p.
|
article
|
| 13 |
Genetic aberrations in paediatric acute leukaemias and implications for management of patients
|
Szczepański, Tomasz
|
|
2010
|
11 |
9 |
p. 880-889
10 p.
|
article
|
| 14 |
HBV infection as a risk factor for non-Hodgkin lymphoma
|
Jeong, Sook-Hyang
|
|
2010
|
11 |
9 |
p. 806-
1 p.
|
article
|
| 15 |
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study
|
Engels, Eric A
|
|
2010
|
11 |
9 |
p. 827-834
8 p.
|
article
|
| 16 |
H2Oil
|
Burki, Talha
|
|
2010
|
11 |
9 |
p. 825-826
2 p.
|
article
|
| 17 |
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
|
Beauchesne, Patrick
|
|
2010
|
11 |
9 |
p. 871-879
9 p.
|
article
|
| 18 |
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
|
Muro, Kei
|
|
2010
|
11 |
9 |
p. 853-860
8 p.
|
article
|
| 19 |
Is there really a yin and yang to VEGF-targeted therapies?
|
Ellis, Lee M
|
|
2010
|
11 |
9 |
p. 809-811
3 p.
|
article
|
| 20 |
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
|
Maas, Monique
|
|
2010
|
11 |
9 |
p. 835-844
10 p.
|
article
|
| 21 |
NICE issues guidance on cancer of unknown primary
|
MacReady, Norra
|
|
2010
|
11 |
9 |
p. 824-
1 p.
|
article
|
| 22 |
Pathological complete response: still a relevant endpoint in rectal cancer?
|
Chua, Yu Jo
|
|
2010
|
11 |
9 |
p. 807-808
2 p.
|
article
|
| 23 |
PET in women with high risk for breast or ovarian cancer
|
Even-Sapir, Einat
|
|
2010
|
11 |
9 |
p. 899-905
7 p.
|
article
|
| 24 |
Regulation of circadian rhythms and hypothalamic-pituitary-adrenal axis: an overlooked interaction in cancer
|
Innominato, Pasquale F
|
|
2010
|
11 |
9 |
p. 816-817
2 p.
|
article
|
| 25 |
Safety of denosumab in giant-cell tumour of bone
|
Thomas, David
|
|
2010
|
11 |
9 |
p. 815-
1 p.
|
article
|
| 26 |
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium
|
Sonpavde, Guru
|
|
2010
|
11 |
9 |
p. 861-870
10 p.
|
article
|
| 27 |
S-1 for advanced colorectal cancer: do we need another oral fluorouracil prodrug?
|
Schmoll, Hans-Joachim
|
|
2010
|
11 |
9 |
p. 808-809
2 p.
|
article
|
| 28 |
Testicular haemangiomas and vascular malformations
|
Fernandez-Pineda, Israel
|
|
2010
|
11 |
9 |
p. 814-
1 p.
|
article
|
| 29 |
The sentinel-node concept: a dramatic improvement in breast-cancer surgery
|
Berveiller, Paul
|
|
2010
|
11 |
9 |
p. 906-
1 p.
|
article
|
| 30 |
When Cancer Crosses Disciplines
|
Schwartzberg, Lee
|
|
2010
|
11 |
9 |
p. 826-
1 p.
|
article
|
| 31 |
When the evidence is weak, caution should be applied
|
The Lancet Oncology,
|
|
2010
|
11 |
9 |
p. 805-
1 p.
|
article
|
Journal description